Literature DB >> 17363518

The biology of metastasis to a sanctuary site.

Diane Palmieri1, Ann F Chambers, Brunhilde Felding-Habermann, Suyun Huang, Patricia S Steeg.   

Abstract

Metastasis to the brain is prevalent in solid tumors and lymphomas, and is associated with shortened survival. The brain is regarded as a sanctuary site for metastatic tumor cells where they exist partially protected from drugs by the blood-tumor barrier. Model systems for brain metastasis have been developed and are now yielding mechanistic insights into the roles of angiogenesis, energy metabolism, the Her-2 and Stat3 signaling pathways, and dormancy. Specific, new approaches to combat brain metastatic disease are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363518     DOI: 10.1158/1078-0432.CCR-06-2659

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  60 in total

1.  Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.

Authors:  Lixia Guo; Dominic Fan; Fahao Zhang; Janet E Price; Ju-Seog Lee; Dario Marchetti; Isaiah J Fidler; Robert R Langley
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Joseph A Frank
Journal:  Clin Exp Metastasis       Date:  2011-11-01       Impact factor: 5.150

Review 3.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

4.  Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Melissa Smith-Brown; Joseph A Frank
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

Review 5.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

6.  Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.

Authors:  Wen-Tai Chiu; Hsueh-Te Lee; Feng-Ju Huang; Kenneth D Aldape; Jun Yao; Patricia S Steeg; Cheng-Yang Chou; Zhimin Lu; Keping Xie; Suyun Huang
Journal:  Cancer Res       Date:  2011-05-27       Impact factor: 12.701

7.  MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.

Authors:  Lixin Zhang; Peggy S Sullivan; Jerry C Goodman; Preethi H Gunaratne; Dario Marchetti
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 8.  Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Authors:  Shannon Puhalla; William Elmquist; David Freyer; Lawrence Kleinberg; Chris Adkins; Paul Lockman; John McGregor; Leslie Muldoon; Gary Nesbit; David Peereboom; Quentin Smith; Sara Walker; Edward Neuwelt
Journal:  Neuro Oncol       Date:  2015-05       Impact factor: 12.300

Review 9.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

10.  Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation.

Authors:  Melissa Seelbach; Lei Chen; Anita Powell; Yean Jung Choi; Bei Zhang; Bernhard Hennig; Michal Toborek
Journal:  Environ Health Perspect       Date:  2009-10-28       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.